An acquired down-regulation of Dnase1 expression during the development of lupus nephritis could be relevant to understand how systemic autoimmunity translates into end-organ disease, and could prove useful as a clinical marker for renal disease in SLE, as discussed by Mortensen et al. [42]. This evidence concerns the gene DNASE1 and systemic lupus erythematosus.